Z-0562-2021 Class II Terminated
FDA device recall Z-0562-2021 was initiated by Becton, Dickinson And Company, BD Biosciences on Oct 5, 2020 and is designated Class II. Reason for recall: Recent product complaints showing an unexpected cell population exhibiting dim CD3 expression that may result in inaccurate results gating. The recall status is terminated (terminated Mar 11, 2022). Affected quantity: 619 vials.
Recall details
- Product Type
- Devices
- Report Date
- Dec 16, 2020
- Initiation Date
- Oct 5, 2020
- Termination Date
- Mar 11, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 619 vials
Product description
Reason for recall
Distribution pattern
Worldwide distribution - US Nationwide distribution including in the states of AL, CA, CO, CT, DE, FL, GA, IL, IN, KY, MA, MD, MI, NC, NJ, NV, NY, OH, OK, PA, PR, RI, SD, TN, TX, and VA. The countries of Canada, Belgium, Korea, India, Ecuador, Japan, Costa Rica, Australia, Vietnam, Pakistan, Singapore, Thailand, and Peru.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0562-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026